Expression Profiling of Genes Related to Endothelial Cells Biology in Patients with Type 2 Diabetes and Patients with Prediabetes
Table 1
Clinical characteristics of the participants in the different groups.
Group 1
Group 2
Group 3
Age (years)
50.33 ± 6.58
47.8 ± 6.24
48.8 ± 4.07
BMI (kg/m2)
25.88 ± 1.76
26.97 ± 1.24
26.40 ± 1.21
Fasting glucose (mmol/L)
11.60 ± 2.17
6.52 ± 0.34
4.72 ± 0.33
HbA1c%
12.15 ± 2.01
6.24 ± 0.15
5.00 ± 0.32
HDL (mmol/L)
1.63 ± 0.13
1.72 ± 0.15
1.74 ± 0.56
LDL (mmol/L)
2.22 ± 0.39
2.19 ± 0.38
2.58 ± 0.52
Triglycerides (mmol/L)
1.45 ± 0.23
1.22 ± 0.30
1.02 ± 0.15
Total cholesterol (mmol/L)
4.79 ± 0.83
4.51 ± 0.60
4.26 ± 0.35
WBC (×109/L)
6.17 ± 1.54
5.61 ± 1.33
4.95 ± 1.55
Neutrophils (×109/L)
3.41 ± 1.58
2.54 ± 1.14
2.41 ± 1.11
Lymphocytes (×109/L)
2.14 ± 0.35
1.89 ± 0.91
1.81 ± 0.53
Monocytes (×109/L)
0.46 ± 0.13
0.41 ± 0.17
0.45 ± 0.12
Eosinophils (×109/L)
0.18 ± 0.11
0.19 ± 0.13
0.14 ± 0.12
Basophils (×109/L)
0.04 ± 0.09
0.03 ± 0.06
0.03 ± 0.03
Group 1: T2DM patients; group 2: patients with prediabetes; group 3: control group. Values shown are the mean ± standard deviation (SD). indicates significantly different versus control ( < 0.05).
